SCHEMBL5849530

SCHEMBL5849530

C#Cc1cc2c(N3CCN(C(=O)OC(C)(C)C)CC3)ncnc2s1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KIT P10721 2/20 0.52
P2RY12 Q9H244 6/20 0.46
ALDH1A1 P00352 2/20 0.46
KDM4E B2RXH2 1/20 0.46
MEN1 O00255 6/20 0.45
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
KMT2A Q03164 2/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
MAP4K4 O95819 1/20 0.41
GPR119 Q8TDV5 1/20 0.40
HRH4 Q9H3N8 1/20 0.40
GBA1 P04062 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5849376 0.90 KIT (0.52) KITP2RY12ALDH1A1KDM4EMEN1
SCHEMBL5851682 0.85 KIT (0.55) KITP2RY12ALDH1A1KDM4EMEN1
SCHEMBL5848798 0.84 KIT (0.57) KITP2RY12ALDH1A1KDM4EMEN1
SCHEMBL5851315 0.84 KIT (0.54) KITP2RY12ALDH1A1KDM4EMEN1
SCHEMBL5850542 0.84 KIT (0.54) KITP2RY12ALDH1A1KDM4EMEN1
SCHEMBL7064496 0.83 ALDH1A1 (0.52) P2RY12ALDH1A1KDM4EMEN1MAPT
SCHEMBL5849579 0.83 KIT (0.53) KITP2RY12ALDH1A1KDM4EMEN1
SCHEMBL5850552 0.82 P2RY12 (0.68) P2RY12ALDH1A1KDM4EMEN1MAPT
SCHEMBL5851715 0.80 MAPT (0.57) KITP2RY12ALDH1A1KDM4EMEN1
SCHEMBL5849427 0.80 P2RY12 (0.57) KITP2RY12ALDH1A1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115741-B2 4-thieno[2,3-D]pyrimidin-4-YL piperazine compounds ALEXION PHARMACEUTICALS, INC. 2006-10-03 US disclosed
WO-2003022214-A2 PIPERAZINE AND HOMOPIPERAZINE COMPOUNDS MILLENNIUM PHARMACEUTICALS, INC. (US) 2003-03-20 WO disclosed